Berkeley, California
United States
82
2026-03-12
60
2025-09-16
These are the the leading inventors for applications assigned to Caribou Biosciences, Inc.:
Caribou Biosciences, Inc. based in Berkeley, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ENGINEERED CASCADE COMPONENTS AND CASCADE COMPLEXES
#2 | 2026-02-05CYTOKINE-RECEPTOR FUSIONS FOR IMMUNE CELL STIMULATION
#3 | 2026-01-15COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
#4 | 2025-12-11CRISPR HYBRID DNA/RNA POLYNUCLEOTIDES AND METHODS OF USE
#5 | 2025-11-13TREATMENT OF AUTOIMMUNE DISEASES WITH ENGINEERED IMMUNE CELLS
#6 | 2025-11-06ANTI-ROR1 ANTIBODY AND ROR1-TARGETING ENGINEERED CELLS
#7 | 2025-10-30ANTI-CLL-1 CHIMERIC ANTIGEN RECEPTORS, ENGINEERED CELLS AND RELATED METHODS
#8 | 2025-10-23MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#9 | 2025-10-23THERAPEUTIC APPLICATIONS OF CRISPR TYPE V SYSTEMS
#10 | 2025-10-16COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
#11 | 2025-07-17MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#12 | 2025-07-10MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#13 | 2025-05-22HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS
#14 | 2025-03-20TREATMENT OF AUTOIMMUNE DISEASES WITH ENGINEERED IMMUNE CELLS
#15 | 2025-01-30 ✅ Patent 12,416,045 granted on 2025-09-16A METHOD OF CAPTURING CRISPR ENDONUCLEASE CLEAVAGE PRODUCTS
#16 | 2025-01-23DNA-CONTAINING POLYNUCLEOTIDES AND GUIDES FOR CRISPR TYPE V SYSTEMS, AND METHODS OF MAKING AND USING THE SAME
#17 | 2025-01-16EXONUCLEASE-COUPLED REAL-TIME ENDONUCLEASE ACTIVITY ASSAY
#18 | 2024-10-24ANTI-ROR1 CHIMERIC ANTIGEN RECEPTORS (CARS), CELLS EXPRESSING THE CARS AND RELATED METHODS
#19 | 2024-07-18 ✅ Patent 12,492,264 granted on 2025-12-09ANTI-ROR1 ANTIBODY AND ROR1-TARGETING ENGINEERED CELLS
#20 | 2024-06-06 ✅ Patent 12,435,152 granted on 2025-10-07HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS
#21 | 2024-05-30MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#22 | 2024-05-23COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
#23 | 2023-11-30 ✅ Patent 11,932,703 granted on 2024-03-19Anti-ROR1 antibody and ROR1-targeting engineered cells
#24 | 2023-06-22 ✅ Patent 12,644,138 granted on 2026-06-02CRISPR HYBRID DNA/RNA POLYNUCLEOTIDES AND METHODS OF USE
#25 | 2022-11-03CRISPR ABASIC RESTRICTED NUCLEOTIDES AND CRISPR ACCURACY VIA ANALOGS
#26 | 2022-07-14 ✅ Patent 11,472,884 granted on 2022-10-18Humanized BCMA antibody and BCMA-CAR-T cells
#27 | 2022-01-20 ✅ Patent 11,299,549 granted on 2022-04-12Humanized BCMA antibody and BCMA-CAR-T cells
#28 | 2021-12-02 ✅ Patent 11,459,588 granted on 2022-10-04Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides
#29 | 2021-09-09 ✅ Patent 11,142,583 granted on 2021-10-12BCMA-CAR-natural killer (NK) cells and methods related thereto
#30 | 2021-07-15 ✅ Patent 12,103,956 granted on 2024-10-01Suicide module compositions and methods
#31 | 2021-06-10 ✅ Patent 11,939,604 granted on 2024-03-26Modified cascade ribonucleoproteins and uses thereof
#32 | 2021-05-27 ✅ Patent 11,021,542 granted on 2021-06-01Humanized BCMA antibody and BCMA-CAR-T cells
#33 | 2021-04-08 ✅ Patent 12,227,776 granted on 2025-02-18Engineered cascade components and cascade complexes
#34 | 2021-01-07 ✅ Patent 11,555,181 granted on 2023-01-17Engineered cascade components and cascade complexes
#35 | 2020-12-24 ✅ Patent 10,927,182 granted on 2021-02-23Humanized BCMA antibody and BCMA-CAR-T cells
#36 | 2020-11-12 ✅ Patent 10,988,781 granted on 2021-04-27Method of target cleaving using CRISPR hybrid DNA/RNA polynucleotides
#37 | 2020-10-15 ✅ Patent 10,954,498 granted on 2021-03-23Modified cascade ribonucleoproteins and uses thereof
#38 | 2020-10-08 ✅ Patent 11,225,649 granted on 2022-01-18Engineered nucleic-acid targeting nucleic acids
#39 | 2020-09-03 ✅ Patent 10,781,432 granted on 2020-09-22Engineered cascade components and cascade complexes
#40 | 2020-07-02 ✅ Patent 11,001,843 granted on 2021-05-11Engineered nucleic acid-targeting nucleic acids
#41 | 2020-03-05 ✅ Patent 10,711,258 granted on 2020-07-14Engineered nucleic-acid targeting nucleic acids
#42 | 2020-02-20 ✅ Patent 11,236,364 granted on 2022-02-01CRISPR hybrid DNA/RNA polynucleotides and methods of use
#43 | 2020-02-13 ✅ Patent 10,597,648 granted on 2020-03-24Engineered cascade components and cascade complexes
#44 | 2020-02-06 ✅ Patent 10,711,257 granted on 2020-07-14Modified cascade ribonucleoproteins and uses thereof
#45 | 2019-10-29 ✅ Patent 10,457,922 granted on 2019-10-29Engineered cascade components and cascade complexes
#46 | 2019-08-29PROTEIN ENGINEERING METHODS
#47 | 2019-06-25 ✅ Patent 10,329,547 granted on 2019-06-25Engineered cascade components and cascade complexes
#48 | 2019-04-18 ✅ Patent 10,501,728 granted on 2019-12-10Engineered nucleic-acid targeting nucleic acids
#49 | 2019-04-04 ✅ Patent 11,505,808 granted on 2022-11-22Engineered nucleic acid-targeting nucleic acids
#50 | 2019-03-12 ✅ Patent 10,227,576 granted on 2019-03-12Engineered cascade components and cascade complexes
#51 | 2019-02-21 ✅ Patent 11,155,814 granted on 2021-10-26Methods for using DNA repair for cell engineering
#52 | 2019-02-07 ✅ Patent 10,196,619 granted on 2019-02-05Engineered nucleic-acid targeting nucleic acids
#53 | 2018-12-06 ✅ Patent 10,125,354 granted on 2018-11-13Engineered nucleic-acid targeting nucleic acids
#54 | 2018-11-01 ✅ Patent 10,138,472 granted on 2018-11-27Engineered nucleic-acid targeting nucleic acids
#55 | 2018-09-06 ✅ Patent 10,100,333 granted on 2018-10-16Engineered nucleic acid-targeting nucleic acids
#56 | 2018-08-30 ✅ Patent 11,111,506 granted on 2021-09-07Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
#57 | 2018-07-19 ✅ Patent 10,023,853 granted on 2018-07-17Engineered nucleic-acid targeting nucleic acids
#58 | 2018-06-21 ✅ Patent 10,125,375 granted on 2018-11-13Methods of modifying a target nucleic acid with an Argonaute
#59 | 2018-05-03 ✅ Patent 9,970,029 granted on 2018-05-15Engineered nucleic acid-targeting nucleic acids
#60 | 2018-05-03 ✅ Patent 10,435,678 granted on 2019-10-08Modified cascade ribonucleoproteins and uses thereof
#61 | 2018-05-03 ✅ Patent 9,957,490 granted on 2018-05-01Cells comprising engineered nucleic-acid targeting nucleic acids
#62 | 2017-11-23 ✅ Patent 9,970,027 granted on 2018-05-15Compositions and methods of engineered CRISPR-CAS9 systems using split-nexus CAS9-associated polynucleotides
#63 | 2017-11-23 ✅ Patent 9,970,026 granted on 2018-05-15Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
#64 | 2017-11-16 ✅ Patent 9,809,814 granted on 2017-11-07Compositions and methods of nucleic acid-targeting nucleic acids
#65 | 2017-11-14 ✅ Patent 9,816,081 granted on 2017-11-14Engineered nucleic-acid targeting nucleic acids
#66 | 2017-11-14 ✅ Patent 9,816,093 granted on 2017-11-14Engineered nucleic acid-targeting nucleic acids
#67 | 2017-07-20 ✅ Patent 9,745,562 granted on 2017-08-29Methods of using engineered nucleic-acid targeting nucleic acids
#68 | 2017-06-08 ✅ Patent 9,771,600 granted on 2017-09-26Engineered nucleic acid-targeting nucleic acids
#69 | 2017-04-27 ✅ Patent 9,677,090 granted on 2017-06-13Engineered nucleic-acid targeting nucleic acids
#70 | 2017-02-23 ✅ Patent 11,312,953 granted on 2022-04-26Compositions and methods of nucleic acid-targeting nucleic acids
#71 | 2017-02-16 ✅ Patent 9,745,600 granted on 2017-08-29Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
#72 | 2017-02-09 ✅ Patent 9,580,727 granted on 2017-02-28Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
#73 | 2016-11-03 ✅ Patent 9,725,714 granted on 2017-08-08Compositions and methods of nucleic acid-targeting nucleic acids
#74 | 2016-10-27 ✅ Patent 9,803,194 granted on 2017-10-31Compositions and methods of nucleic acid-targeting nucleic acids
#75 | 2016-09-08 ✅ Patent 9,970,030 granted on 2018-05-15Methods for increasing CAS9-mediated engineering efficiency
#76 | 2016-09-01 ✅ Patent 10,125,361 granted on 2018-11-13Compositions and methods of nucleic acid-targeting nucleic acids
#77 | 2016-06-30 ✅ Patent 9,885,026 granted on 2018-02-06Modified cascade ribonucleoproteins and uses thereof
#78 | 2016-04-21 ✅ Patent 9,909,122 granted on 2018-03-06Compositions and methods of nucleic acid-targeting nucleic acids
#79 | 2016-02-18 ✅ Patent 9,410,198 granted on 2016-08-09Compostions and methods of nucleic acid-targeting nucleic acids
#80 | 2016-01-28 ✅ Patent 9,260,752 granted on 2016-02-16Compositions and methods of nucleic acid-targeting nucleic acids
#81 | 2015-03-26 ✅ Patent 9,902,973 granted on 2018-02-27Methods of modifying a target nucleic acid with an argonaute
#82 | 2014-10-23COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
Also check out Caribou Biosciences, Inc.'s (Berkeley, United States) applicant profile with 80 patent applications submitted.
80846 ⎘